Neurocritical Care News

Biopharmaceutical company DiaMedica Therapeutics Inc. announced that the FDA placed a clinical hold on its phase 2/3 ReMEDy2 trial of a synthetic protein therapy for treatment of acute ischemic stroke.

Cerebrospinal fluid diversion was not associated with improved outcome for children following a traumatic brain injury. However, a decrease in intracranial pressure was observed, researchers reported in JAMA Network Open.

The American Academy of Neurology has issued a statement in support of protections surrounding the physician-patient relationship, following the U.S. Supreme Court’s decision to overturn Roe v. Wade.

Individuals aged 65 years and older with a history of hypothyroidism were associated with an 81% increased risk for dementia, researchers reported in Neurology.

Antibodies produced in response to COVID-19 may mistakenly target cells essential to the blood-brain barrier, which can cause bleeds and clots in patients and increase the risk for stroke, researchers reported in Brain.

Continuous subcutaneous infusion of foslevodopa/foscarbidopa was safe and improved motor complications in patients with advanced Parkinson’s disease, according to data presented at the European Academy of Neurology Congress 2022.

A thin optical fiber shows promise for use in minimally invasive deep tissue studies in brains affected by Alzheimer’s disease, researchers reported in APL Photonics.

Mdoloris, a company specializing in medical pain monitoring technologies, announced its latest device, a bracelet that can record and track the pain and well-being of those who are unable to verbalize or indicate what they are feeling.

In children with epilepsy who discontinue anti-seizure medications, the risk for seizure relapse was significantly associated with younger age at diagnosis, according to a study published in Epilepsy & Behavior.

Men who experience behavioral changes, such as apathy or hallucinations, are at a faster risk for cognitive decline compared with women, findings published in the Journal of Alzheimer’s Disease showed.